Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs
Metadata
Title
Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin
Rationale for Use in Solid Tumours
Authors
Dr A. Gabizon
F. Martin
Publication date
01-10-1997
Publisher
Springer International Publishing
Published in
Drugs / Issue Special Issue 4/1997
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-199700544-00005

Other articles of this Special Issue 4/1997

Drugs 4/1997 Go to the issue

OriginalPaper

Safety Aspects of Pegylated Liposomal Doxorubicin in Patients with Cancer

OriginalPaper

Clinical Efficacy and Prospects for Use of Pegylated Liposomal Doxorubicin in the Treatment of Ovarian and Breast Cancers

OriginalPaper

Anthracyclines in the Treatment of Cancer

OriginalPaper

Liposomes